TY - JOUR
T1 - Identification of a PTEN mutation in a family with cowden syndrome and Bannayan-Zonana syndrome
AU - Wanner, Molly
AU - Çelebi, Julide Tok
AU - Peacocke, Monica
N1 - Funding Information:
Supported in part by grants from the National Cancer Institute (RO-1 CA-66693 and RO-1 CA-70519 to M. P.), the National Institute on Aging (K-04 AG-00694 to M. P.), and the National Institute of Arthritis and Musculoskeletal and Skin Diseases, Skin Disease Research Center (PO-30 AR44535, to David R. Bickers).
PY - 2001
Y1 - 2001
N2 - Cowden syndrome (CS) and Bannayan-Zonana syndrome (BZS) are two inherited hamartoma syndromes characterized by distinct phenotypic features. Mutation in the PTEN gene have been identified in patients with CS and BZS, suggesting the presence of a common genetics basis. We describe a single kindred with individuals manifesting both CS and BZS phenotypes (CS/BZS overlap family) in which we have identified a novel mutation in PTEN by DNA sequencing. We have confirmed these results by means of restriction enzyme analysis. The presence of individuals with CS and BZS within the same family, and moreover the identification of identical PTEN gene mutations in these individuals, suggest that these two syndromes represent different phenotypic expressions of one disease. Furthermore, these findings imply that, like patients with CS, individuals with BZS should be monitored for the onset of malignancy.
AB - Cowden syndrome (CS) and Bannayan-Zonana syndrome (BZS) are two inherited hamartoma syndromes characterized by distinct phenotypic features. Mutation in the PTEN gene have been identified in patients with CS and BZS, suggesting the presence of a common genetics basis. We describe a single kindred with individuals manifesting both CS and BZS phenotypes (CS/BZS overlap family) in which we have identified a novel mutation in PTEN by DNA sequencing. We have confirmed these results by means of restriction enzyme analysis. The presence of individuals with CS and BZS within the same family, and moreover the identification of identical PTEN gene mutations in these individuals, suggest that these two syndromes represent different phenotypic expressions of one disease. Furthermore, these findings imply that, like patients with CS, individuals with BZS should be monitored for the onset of malignancy.
UR - http://www.scopus.com/inward/record.url?scp=0035113511&partnerID=8YFLogxK
U2 - 10.1067/mjd.2001.110390
DO - 10.1067/mjd.2001.110390
M3 - Article
AN - SCOPUS:0035113511
SN - 0190-9622
VL - 44
SP - 183
EP - 187
JO - Journal of the American Academy of Dermatology
JF - Journal of the American Academy of Dermatology
IS - 2
ER -